Association for Innovation and Biomedical Research on Light and Image (AIBILI)
This sponsor has funded 4 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 31461 | Ongoing | The portuguese Survey on anTicoagulated pAtients RegisTer (START-Portugal-Register) | No | No |
| 31738 | Planned | Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for... | No | No |
| 35531 | Planned | The risk of infections associated with JAK inhibitors in rheumatoid arthritis: a protocol for a systematic review and meta-analysis | No | No |
| 35534 | Finalised | The risk of cardiovascular adverse effects associated with JAK inhibitors in rheumatoid arthritis: a protocol for a systematic review and... | Yes | No |
PAS by Risk Management Plan (RMP) requirement
Association for Innovation and Biomedical Research on Light and Image (AIBILI)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Association for Innovation and Biomedical Research on Light and Image (AIBILI)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Association for Innovation and Biomedical Research on Light and Image (AIBILI)
1 Study countries specified are the following:
- Portugal